Physician profile
Jason D Zagrodzky
NPI 1912982018
$960,858.20
in general payments reported to CMS, 2019-2025
27 companies · $107K in 2025
The $107K reported for 2025 was more than what 98% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89K · 2020: $111K · 2021: $68K · 2022: $103K · 2023: $87K · 2024: $396K · 2025: $107K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $308K · Consulting Fee: $259K · Food and Beverage: $12K · Travel and Lodging: $8,639 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $307,644.17 |
| Consulting Fee | $259,450.00 |
| Food and Beverage | $12,335.13 |
| Travel and Lodging | $8,638.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,152.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $330,443.24 | 2024 | Ensoetm |
| Medical Device Business Services, INC. | $285,500.58 | 2019-2025 | Carto 3 |
| Biosense Webster, INC. | $275,824.15 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Sanofi-Aventis U.S. LLC | $26,286.51 | 2019-2024 | |
| Abbott Laboratories | $24,213.98 | 2019-2025 | Perclose Proglide, Aveir, Assurity |
| Janssen Pharmaceuticals, INC | $5,661.83 | 2019-2024 | Xarelto |
| Medtronic, INC. | $3,223.72 | 2021-2024 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Linq II |
| Atricure, INC. | $2,218.70 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Cardiva Medical, INC. | $1,983.29 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm |
| Pfizer INC. | $1,657.08 | 2019-2025 | |
| Boston Scientific Corporation | $1,206.35 | 2019-2024 | |
| Cvrx, INC. | $877.32 | 2022-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $376.61 | 2019-2023 | Eliquis, Camzyos |
| Impulse Dynamics (USA) INC. | $371.76 | 2021-2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $338.04 | 2019-2025 | Lifevest |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $198.84 | 2024-2025 | Hemosphere |
| Irhythm Technologies, INC. | $126.17 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Baxter Healthcare | $101.82 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Johnson & Johnson Health Care Systems INC. | $67.58 | 2019 | |
| Medtronic Vascular, INC. | $42.90 | 2020 | |
| Biotronik INC. | $27.99 | 2020 | |
| Globus Medical, INC. | $25.73 | 2025 | Senza |
| Convatec INC. | $19.39 | 2021 | |
| Merck Sharp & Dohme LLC | $18.43 | 2023 | Verquvo, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.88 | 2021 | |
| Bardy Diagnostics, INC. | $15.31 | 2021 | |
| Zoll Respicardia, INC. | $15.00 | 2025 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Zagrodzky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.